Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BLISS GVS PHARMA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BLISS GVS PHARMA PANACEA BIOTECH BLISS GVS PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x 13.1 -60.5 - View Chart
P/BV x 1.3 0.9 153.6% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 BLISS GVS PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    BLISS GVS PHARMA
Mar-23
PANACEA BIOTECH
Mar-23
BLISS GVS PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs91191 47.7%   
Low Rs67107 62.8%   
Sales per share (Unadj.) Rs72.275.1 96.1%  
Earnings per share (Unadj.) Rs7.4-5.5 -133.7%  
Cash flow per share (Unadj.) Rs9.20.9 1,043.3%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs84.0137.7 61.0%  
Shares outstanding (eoy) m104.1561.25 170.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.12.0 55.3%   
Avg P/E ratio x10.8-27.1 -39.7%  
P/CF ratio (eoy) x8.7170.0 5.1%  
Price / Book Value ratio x0.91.1 87.1%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m8,2629,142 90.4%   
No. of employees `000NANA-   
Total wages/salary Rs m8621,265 68.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m7,5164,599 163.4%  
Other income Rs m178517 34.4%   
Total revenues Rs m7,6945,116 150.4%   
Gross profit Rs m1,17347 2,495.2%  
Depreciation Rs m187391 47.7%   
Interest Rs m10444 233.6%   
Profit before tax Rs m1,061128 828.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m293466 63.0%   
Profit after tax Rs m767-337 -227.4%  
Gross profit margin %15.61.0 1,527.0%  
Effective tax rate %27.7363.5 7.6%   
Net profit margin %10.2-7.3 -139.2%  
BALANCE SHEET DATA
Current assets Rs m6,9745,623 124.0%   
Current liabilities Rs m1,9333,297 58.6%   
Net working cap to sales %67.150.6 132.6%  
Current ratio x3.61.7 211.6%  
Inventory Days Days3959 65.8%  
Debtors Days Days1,87148 3,922.5%  
Net fixed assets Rs m4,5627,028 64.9%   
Share capital Rs m10461 170.0%   
"Free" reserves Rs m8,6468,375 103.2%   
Net worth Rs m8,7508,436 103.7%   
Long term debt Rs m407202 201.8%   
Total assets Rs m11,53512,712 90.7%  
Interest coverage x11.23.9 289.1%   
Debt to equity ratio x00 194.6%  
Sales to assets ratio x0.70.4 180.1%   
Return on assets %7.6-2.3 -327.5%  
Return on equity %8.8-4.0 -219.2%  
Return on capital %12.72.0 637.0%  
Exports to sales %043.3 0.0%   
Imports to sales %024.4 0.0%   
Exports (fob) Rs mNA1,992 0.0%   
Imports (cif) Rs mNA1,124 0.0%   
Fx inflow Rs m5,6181,992 282.0%   
Fx outflow Rs m1,2251,191 102.8%   
Net fx Rs m4,394801 548.3%   
CASH FLOW
From Operations Rs m343-4,225 -8.1%  
From Investments Rs m-784,303 -1.8%  
From Financial Activity Rs m-249-184 135.7%  
Net Cashflow Rs m30-105 -28.8%  

Share Holding

Indian Promoters % 35.0 73.6 47.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 22.0 1.0 2,311.6%  
FIIs % 15.4 0.3 5,907.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 65.0 26.4 246.2%  
Shareholders   40,758 47,091 86.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BLISS GVS PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on BLISS GVS PHARMA vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

BLISS GVS PHARMA vs Panacea Biotech Share Price Performance

Period BLISS GVS PHARMA Panacea Biotech S&P BSE HEALTHCARE
1-Day -1.71% -2.47% 1.18%
1-Month -9.48% -20.61% -0.75%
1-Year 57.63% 10.92% 61.82%
3-Year CAGR 3.76% -12.48% 18.16%
5-Year CAGR -8.82% -10.11% 19.79%

* Compound Annual Growth Rate

Here are more details on the BLISS GVS PHARMA share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of BLISS GVS PHARMA hold a 35.0% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BLISS GVS PHARMA and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, BLISS GVS PHARMA paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.8%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of BLISS GVS PHARMA, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.